Netherlands· NL-932643efe8e4
Drovelis 14,2mg/3 mg, filmomhulde tabletten
A drospirenone and estetrol product containing drospirenon + estetrol 1-water, registered in Netherlands by Gedeon Richter Plc. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Drospirenone and estetrol is registered in 12 of 19 countries.
Countries holding a registration under ATC G03AA18 (drospirenone and estetrol), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Drospirenone and estetrol · ATC G03AA18
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DROSPIRENON + ESTETROL 1-WATER
- Manufacturer
- Gedeon Richter Plc
- Country
- Netherlands (NL)
- ATC code
- G03AA18
- ATC class
- Drospirenone and estetrol
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/21/1547
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Drospirenone and estetrol in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3b5018f0-710f-428c-a18e-1f1c8d2e3893 GET /v1/drugs/3b5018f0-710f-428c-a18e-1f1c8d2e3893?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/drovelis-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Drospirenone And Estetrol",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp126278",
"excipients": [
"HYPROLOSE (E 463)",
"HYPROLOSE (E 463)",
"HYPROMELLOSE (E 464)",
"HYPROMELLOSE (E 464)",
"IJZEROXIDE ROOD (E 172)",
"KATOENZAADOLIE, GEHYDROGENEERD",
"KATOENZAADOLIE, GEHYDROGENEERD",
"LACTOSE 1-WATER",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"MAÏSZETMEEL",
"NATRIUMZETMEELGLYCOLAAT",
"POVIDON K 30 (E 1201)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"DROSPIRENON",
"ESTETROL 1-WATER"
],
"leaflet_url": null,
"authorised_at": "2021/05/19",
"procedure_number": "EMEA/H/C/005336",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/21/1547",
"additional_monitoring": "N"
}See everything about drospirenone and estetrol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.